Suppressors of cytokine signalling: SOCS

APMIS

Volumn 110, Issue 12, 2002, Pages 833-844

  Larsen, Lykke ^a   Röpke, Carsten ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cytokines; Jak; Signalling; SOCS; Stat

Indexed keywords

CIS PROTEIN; CYTOKINE; GAMMA INTERFERON; JANUS KINASE; PHOSPHOTYROSINE; SOCS 4 PROTEIN; SOCS 5 PROTEIN; SOCS 6 PROTEIN; SOCS 7 PROTEIN; STAT PROTEIN; SUPPRESSOR FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; DNA MODIFICATION; EMBRYO DEVELOPMENT; ERYTHROPOIESIS; LYMPHOCYTE DIFFERENTIATION; NEGATIVE FEEDBACK; NONHUMAN; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARRIER PROTEINS; CYSTEINE ENDOPEPTIDASES; CYTOKINES; DNA-BINDING PROTEINS; ERYTHROPOIESIS; GROWTH; HUMANS; IMMEDIATE-EARLY PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MULTIENZYME COMPLEXES; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; RATS; RECEPTORS, CYTOKINE; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0036986179     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2002.1101201.x     Document Type: Review

References (43)

1. Lotem J, Sachs L. Cytokine control of developmental programs in normal hematopoiesis and leukemia. Oncogene. 2002;2:3284-94.
2. Nicola NA. Guidebook to cytokines and their receptors. Oxford University Press, Oxford 1994.
3. Darnell JE Jr. STATs and gene regulation. Science 1998;277:1630-5.
4. Leonard WJ, O'Shea JJ. JAKs and STATs: biological implications. Annu Rev Immunol 1998; 16:293-322.
5. Ihle JN. The Stat family in cytokine signaling. Curr Opin Cell Biol 2001;13:211-7.
6. O'Shea JJ, Gadina M, Schreiber RD. Cytokine signaling in 2002: New surprises in the Jak/Stat pathway. Cell 2002;109:121-31.
7. Hilton DJ. Negative regulators of cytokine signal transduction. Cell Mol Life Sci 1999;55:1568-77.
8. Yoshimura A, Ohkubo T, Kiguchi T, Jenkins NA, Gilbert DJ, Copeland NG, et al. A novel cytokine-induced gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J 1995;14:2816-26.
9. Endo TA, Masuhara M, Yokochi M, Suzuki R, Sakamoto H, Mitsui K, et al. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997;387:921-4.
10. Naka T, Narazaki M, Hirate M, Matsumoto T, Minamoto S, Aono A, et al. Structure and function of a new STAT-induced STAT inhibitor. Nature 1997;387:924-9.
11. Starr R, Willson TA, Viney EM, Murra, LJL, Rayner JR, Jenkins BJ, et al. A family of cytokine-inducible inhibitors of signalling. Nature 1997;387:917-21.
12. Hilton DJ, Richardson RT, Alexander WS, Viney EM, Willson TA, Sprigg NS. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci USA 1998; 95:114-9.
13. Masuhara M, Sakamoto H, Matsumoto A, Suzuki R, Yasukawa H, Mitsui K, et al. Cloning and characterisation of novel CIS family genes. Biochem Biophys Res Commun 1997;239:439-46.
14. Narazaki M, Fujimoto M, Matsumoto T, Morita Y, Saito H, Kajita T, et al. Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling. Proc Natl Acad Sci USA 1998;95:13130-4.
15. Sasaki A, Yasikawa H, Suzuk, A, Kamizono S, Syoda T, Kinjyo I. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells 1999;4:339-51.
16. Metcalf D, Greenhalgh CJ, Viney E, Willson TA, Starr R, Nicola NA, et al. Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 2000;405:1069-73.
17. Marine JC, McKay C, Wang D, Topham DJ, Parganas E, Nakajima H, et al. SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell 1999;98:617-27.
18. Matsumoto A, Masuhara M, Mitsui K, Yokouch, M, Ohtsub, M, Misawa H, et al. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 1997;89,3148-54.
19. Adams TE, Hansen JA, Starr R, Nicola NA. Hilton DJ, Billestrup N. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. J Biol Chem 1998;273:1285-7.
20. Brender C, Nielsen M, Röpke C, Nissen MH, Svejgaard A, Billestrup N, Ødum N. Interferon-alpha induces transient suppressors of cytokine signalling expression in human T cells. Exp Clin Immunogenet. 2001;18:80-5.
21. Haque SJ, Harbor PC, Williams BRG. Identification of critical residues required for suppressor of cytokine signal-specific regulation of interleukin-4 signalling. J Bio Chem 2000;26500-6.
22. Favre H, Benhamou A, Finidori J, Kelly PA, Edery M. Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction. FEBS Lett 1999;453:63-6.
23. Crespo A, Filla MB, Russel SW, Murphy WJ. Indirect induction of suppressors of cytokine signalling-1 in macrophages stimulated with bacterial lipopolysaccharide: partial role of autocrine/paracrine interferon-α/β. Biochem J 2000; 349:99-104.
24. Emanuelli B, Peraldi P, Filloux C, Sawka-Verhelle D, Hilton D, Van Obberghen E. SOCS-3 is an insulin-induced negative regulator of insulin signalling. J Biol Chem 2000;275:15985-91.
25. Suzuki R, Sakamoto H, Yasukawa H, Masuhara M, Wakioka T, Sasaki A, et al. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukaemia cells. Oncogene 1998;17:2271-8.
26. Song MM, Shuai K. The suppressors of cytokine signalling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J Biol Chem 1998;273:35056-62.
27. Casatella MA, Gasperini S, Bovolente C, Calzetti F, Vollebregt M, Scapini P, et al. Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation. Blood 1999;94:2880-9.
28. Nicholson SE, Willson TA, Farley A, Starr R, Zhang JG, Baca M, et al. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J 1999;18:375-85.
29. Yasukawa H, Misawa H, Sakamoto H, Masuhara M, Sasaki A, Wakioka T. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J 1999;18:1309-20.
30. Nicholson SE, De Suoza D, Fabri LJ, Corbin J, Willson TA, Zhang JG, et al. Suppressor of cytokine signalling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp 130. Proc Natl Acid Sci USA 2000; 97:6493-8.
31. Schmitz J, Weissenbach M, Haan S, Heinrich PC, Schaper F. SOCS3 exerts its inhibitory functions on interleukin-6 signal transduction through the SHP2 recruitment site of gp130. J Biol Chem 2000;275:12848-56.
32. Stahl N, Farruggella TJ, Boulton TJ, Zhong Z, Darnell JE Jr, Yancopoulos GD. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 1995;5202:1349-53.
33. Gobert S, Chretien S, Gouilleux F, Muller O, Pallard C, Dusanter-Fourt I, et al. Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation. EMBO 1996;10:2434-41.
34. Dey BR, Spence SL, Nissley P, Furlanetto RW. Interaction of human suppressors of cytokine signalling (SOCS)-2 with insulin-like growth factor-I receptor. J Biol Chem 1998;273:24095-101.
35. Zhang JG, Farley A, Nicholson SE, Willson TA, Zugaro LM, Simpson RJ, et al. The conserved SOCS box motif in the suppressors of cytokine signalling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci USA 1999;96:2071-6.
36. Garrett KP, Aso T, Bradsher JN, Foundling SI, Lane WS, Conaway RC, et al. Positive regulation of general transcription factor SIII by a tailed ubiquitin homolog. Proc Natl Acad Sci USA 1995;16:7172-6.
37. Verdier F, Chrétien S, Muller O, Varlet P, Yoshimura A, Gisselbrecht S, et al. Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. J Biol Chem 1998;273:28185-90.
38. Kamura T, Sato S, Haque D, Liu L, Kaelin WG Jr, Conaway RC, Conaway JW. The elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev 1998;12:3872-81.
39. Alexander WS, Starr R, Fenner JE, Scott CL, Handman E, Sprigg NS, et al. SOCS1 is a critical inhibitor of interferon γ signalling and prevents the potentially fatal neonatal actions of this cytokine. Cell 1999;9:597-608.
40. Naka T, Matsumoto T, Narazaki M, Fujimoto M, Morita Y, Ohsawa Y, et al. Accelerated apoptosis of lymphocytes by augmented induction of BAX in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc Natl Acad Sci USA 1998;95:15577-82.
41. Marine JC, Topham DJ, McKay C, Wang D, Parganas E, Stravopodis D, et al. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 1999;98:609-16.
42. Horvat S, Medrano JF. Lack of socs2 expression causes the high-growth phenotype in mice. Genomics 2001;72:209-12.
43. Roberts AW, Robb L, Rakar S, Hartley L, Cluse L, Nicola NA, et al. Placental defects and embryonic lethality in mice lacking suppressors of cytokine signalling 3. Proc Natl Acad Sci USA 2001;98:9324-9.